Specific types of liver immune cells are required to deal with injury

Liver immune cells are not static following an injury, as previously thought, but they adapt to the new microenvironment and participate in tissue repair

Ghent, 24 January 2025 – Our livers contain many different types of immune cells. New research by the team of Prof. Charlotte Scott (VIB-UGent Center for Inflammation Research) and colleagues now reveals that a specific activation state of one of these cell types is required for tissue repair following injury. This suggests these cells may be useful as new therapeutic targets for various liver conditions. The work appears in the journal Immunity.

Liver immune cells

Macrophages are specialized immune cells located in every tissue of the body, where they play crucial roles in maintaining tissue homeostasis, responding to injury, and facilitating tissue repair. In the healthy liver, most macrophages are classified as Kupffer cells (KCs). However, upon liver injury, as seen, for example, in obesity, another subset of macrophages called lipid-associated macrophages (LAMs) is recruited.

The specific functions of these cells in the context of liver injury were however unclear. Do KCs adapt upon injury to help heal the liver or is this a function for LAMs? ​

New work by the team of Prof. Charlotte Scott (VIB-UGent) and colleagues has addressed this specific question demonstrating that the LAM phenotype is critical for liver repair. Moreover, this research revealed that the KCs are not static post-injury, as previously thought and instead adapt to the new microenvironment also taking on a LAM-like phenotype, allowing them to also participate in the repair. ​

Heterogeneity and plasticity

“We used several advanced research methods, such as single-cell RNA sequencing and spatial transcriptomics, to investigate the heterogeneity, locations, and functions of hepatic macrophages in multiple injury settings,” says Dr. Ania Bujko, from the Scott lab and co-first author of the study, “this allowed us to identify similar populations of LAMs and LAM-like KCs irrespective of the injury type, which were found specifically at the site of injury. ​ This finding was exciting as it suggests these cells may be useful therapeutic targets across various liver diseases.”

However, before the usefulness of these cells as a therapy could be considered, their functional contribution to injury and repair had to be assessed.

“To determine what these populations do in repair, we made use of different animal models to selectively delete genes of interest from the LAMs, LAM-like KCs, or both cells in the various liver injury contexts,” says Federico De Ponti, PhD student in the Scott lab and co-first author of the study. “This revealed that expression of the Trem2 gene is essential in at least one of these populations (LAMs or LAM-like KCs) for the efficient clearance of dying and injured liver cells”.
Federico De Ponti and Dr. Ania Bujko

In other words, loss of TREM2 from both populations prevented repair, whereas repair could occur when expression was maintained in at least one of the populations. So, TREM2 in liver macrophages is critical for promoting tissue repair and preventing excessive fibrosis, suggesting its potential as a therapeutic target.

In addition, the study also demonstrates that the LAM identity is induced in the different macrophage populations through their uptake and clearance of dying cells at the site of injury.

“As this study highlights LAM-like macrophages as a potential therapeutic target to improve liver repair,” says Prof. Scott, “the information that clearance of dying cells drives this activation state could be utilized to generate such cells for therapeutic purposes, bringing us one step closer. While there are still a few questions remaining regarding these cells, that we are now investigating, this study demonstrates that the complex dynamics of hepatic macrophages and their functional roles in liver injury and repair could have significant implications for a variety of liver conditions.”

Publication

Spatially restricted and ontogenically distinct hepatic macrophages populations are required for tissue repair. De Ponti, Bujko, et al. Immunity, 2025.

Funding

ERC, FWO, Wellcome Trust, and German Research Foundation.


Gunnar De Winter

Gunnar De Winter

Science Communications Expert, VIB

 

 

Share

Latest stories

Website preview
Blocking lipid production in healthy lung cells can reduce lung metastasis
Leuven, 17 March 2026 - Scientists from the VIB–KU Leuven Center for Cancer Biology, in collaboration with the Francis Crick Institute, have discovered how cancer cells can exploit healthy lung cells to support metastatic tumor growth in the lungs. In two complementary studies published in Nature Cell Biology and Cancer Discovery, they show that tumors use lipids produced by lung cells as signals, and that decreasing the lipid production of lung cells can decrease metastasis. The findings point to new therapeutic strategies that target lung cell lipid production, rather than cancer cells themselves, which may also help refine patient selection for ongoing clinical trials targeting this pathway.
press.vib.be
Website preview
Researchers identify major genetic risk factor for rare form of dementia
Antwerp, 12 March 2026 - Researchers at VIB and Antwerp University have identified a major genetic risk factor for a rare form of frontotemporal dementia. The discovery, published today in Nature Genetics, provides a biological entry point for a disease subtype that has been difficult to study. It could not only help to improve diagnosis and patient stratification, but also opens up new avenues toward targeted treatments.
press.vib.be
Website preview
Protealis Announces Regulatory Approval of its First Biological Solution MagNfixTM and Launch of Five New Soybean Varieties
Ghent (Belgium), 11 March 2026 – Protealis, the European specialist in non-GMO legume seeds and seed technologies, today announces several milestones that significantly strengthen its position in a fast-growing European soybean market. The company has obtained European regulatory approval from EFCI1 (EU Fertilising Products Regulation (FPR) 2019/1009) for MagNfix™, its first biological solution, which is a proprietary soybean inoculant seed coating that is designed to support higher soybean yield and protein content. In addition, Protealis has secured the registration of five new soybean varieties across four European countries. This includes the introduction of two new maturity group (MG) 000 soybean varieties in Poland, the registration of its first maturity group 0000 ultra-early soybean variety in France, and a new soy variety registration for Belgium. In Germany, Protealis received registration for its second 00 MG soybean variety suited for the regions in southern Germany...
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be